e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Experimental pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Serum osteoprotegerin expression correlates with disease progression and severity in rodent models of pulmonary arterial hypertension
A. Hameed, S. Francis, C. Newman, D. Crossman, A. Lawrie (Sheffield, United Kingdom)
Source:
Annual Congress 2010 - Experimental pulmonary hypertension
Session:
Experimental pulmonary hypertension
Session type:
Thematic Poster Session
Number:
1075
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Hameed, S. Francis, C. Newman, D. Crossman, A. Lawrie (Sheffield, United Kingdom). Serum osteoprotegerin expression correlates with disease progression and severity in rodent models of pulmonary arterial hypertension. Eur Respir J 2010; 36: Suppl. 54, 1075
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Relationship between circulating thrombomodulin levels and latent progression of atherosclerosis in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity
Source: Eur Respir J 2005; 26: Suppl. 49, 21s
Year: 2005
Soluble LR11 level is correlated with the severity of pulmonary hypertension due to left heart disease.
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020
Fibrinogen plasma levels and disease severity in pulmonary artery hypertension
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010
The association between pulmonary arterial hypertension secondary to chronic lung disease and serum asymmetric dimethylarginine levels
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
Serum levels of vascular endothelial growth factor in patients with systemic sclerosis. Correlation with systolic pressure in the pulmonary artery
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007
Plasma levels of circulating cell-free DNA are increased in idiopathic pulmonary fibrosis but do not correlate with disease severity
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019
Elevated serum LOXL2 levels are associated with rapid disease progression in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
How to detect disease progression in pulmonary arterial hypertension
Source: Eur Respir Rev 2012; 21: 40-47
Year: 2012
P-selectin and PDGF serum levels might not be related to idiopathic pulmonary arterial hypertension and schistosomiasis
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010
L-arginine plasma levels correlate with severity of primary pulmonary hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 560s
Year: 2004
Relationship between serum levels of testosterone and the severity of chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020
Serum levels of microRNA-125a are decreased in patients with precapillary pulmonary hypertension and correlate inversely with hemodynamics
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Differences in cellular expression of C-reactive protein and serum amyloid A in lung tissue in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012
C-reactive protein and serum amyloid A overexpression in lung tissues of chronic obstructive pulmonary disease patients
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012
Increased TNFα production in whole blood is associated with disease severity in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 497s
Year: 2002
Serum leptin levels in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 259s
Year: 2002
Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis
Source: Eur Respir J 2014; 43: 1530-1532
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept